Johnson & Johnson (JNJ)
JNJ · Health Care · 
United States
Johnson & Johnson (JNJ) is a US company in the Health Care sector. Johnson & Johnson develops and sells prescription medicines and medical technology. The Innovative Medicine segment covers areas such as oncology, immunology and neuroscience; the MedTech segment sells surgical, orthopedic, cardiovascular and vision products. The consumer health business with brands such as Neutrogena and Tylenol was separated in 2023 as Kenvue. Founded in 1886, the company is based in New Brunswick, New Jersey.
The stock has its largest weight in XUHL (MSCI USA Health Care), at 9.88%. Anyone who holds an ETF containing Johnson & Johnson also has an indirect stake in the company.
Data and Charts: Johnson & Johnson
Key Data for Johnson & Johnson
Johnson & Johnson Stock Price Chart
The Johnson & Johnson chart shows daily closing prices and is set to the current year by default. The stock is up 32.0% year to date and up 44.5% over twelve months. The last recorded close on October 30, 2026, was $273.20, at 94% of the 52-week range.
Price series from our database since Jul 11, 2024, 580 daily values.
Johnson & Johnson Stock Performance
| Year to date | +32.0% | 1 year | +44.5% |
|---|---|---|---|
| 1 month | +3.2% | 3 months | +6.6% |
| Calendar year 2025 | +43.1% |
Measured in euros, Johnson & Johnson is up 38.8% year to date and up 49.4% over twelve months. The difference from the dollar figures above comes from the exchange rate alone. Each daily price is converted at the ECB euro reference rate for that day.
Alysly Data Analysis: Johnson & Johnson
Johnson & Johnson Connections
The map shows how Johnson & Johnson connects to ETFs, indices and other names. Each link is based on measured data and is not a recommendation.
- MSCI USA Health Care Index · contains
- MSCI World Health Care Index · contains
- MSCI World Minimum Volatility Index · contains
- MSCI World Momentum Index · contains
- United States Country · domicile
- XUHL ETF · holds
- CIND ETF · holds
- SPYD ETF · holds
- XUHC ETF · holds
- XDEQ ETF · holds
- XDEB ETF · holds
- XDEM ETF · holds
- XDWH ETF · holds
- SPFS ETF · holds
- Health Care Sector · sector
What ETF Is Johnson & Johnson In?
Johnson & Johnson has very high ETF coverage and is held by 25 of the 104 ETFs we track, which together follow 14 indices. That puts the stock in more ETFs than 92.5% of the 4,341 stocks we track.
| ETF | Index | Weight | per €1,000 in the ETF |
|---|---|---|---|
| XUHL / XUHC | MSCI USA Health Care | 9.88% | €98.75 |
| SPFS | MSCI World Health Care | 7.31% | €73.13 |
| XDWH | MSCI World Health Care | 7.30% | €73.04 |
| CIND | Dow Jones | 3.12% | €31.20 |
| XDEM | MSCI World Momentum | 2.63% | €26.34 |
| XDEB | MSCI World Minimum Volatility | 1.48% | €14.80 |
| XDEQ | MSCI World Quality | 1.27% | €12.75 |
| SXR8 | S&P 500 | 1.00% | €10.00 |
| SPYL / SPY5 | S&P 500 | 1.00% | €9.97 |
| XD9U / XD9D | MSCI USA | 0.99% | €9.93 |
| SPYD | S&P High Yield Dividend Aristocrats | 0.95% | €9.53 |
| SWWD | MSCI World | 0.73% | €7.26 |
| SPPW | MSCI World | 0.73% | €7.26 |
| XDWD / XDWL | MSCI World | 0.73% | €7.26 |
| EUNL | MSCI World | 0.72% | €7.20 |
| WIMI | MSCI World IMI | 0.65% | €6.49 |
| SPYY | MSCI ACWI | 0.65% | €6.45 |
| IUSQ | MSCI ACWI | 0.64% | €6.40 |
| SPYI / SPSA | MSCI ACWI IMI | 0.53% | €5.32 |
| XDEW | S&P 500 Equal Weight | 0.20% | €2.00 |
The last column shows how much of €1,000 in one of these funds goes to Johnson & Johnson, based on each fund's latest holdings list.
US-listed ETFs holding Johnson & Johnson (weight per latest SEC filing): VYM 2.51%, IVV 0.95%, SPY 0.95%, VOO 0.95%, VTI 0.84%. These funds are registered in the US; retail investors in the EU usually cannot buy them.
Johnson & Johnson Weight in iShares Core MSCI World (EUNL) Since 2019
In iShares Core MSCI World (EUNL), Johnson & Johnson had a weight of 0.83% on Sep 30, 2019 and 0.72% on Oct 29, 2026. The fund tracks the MSCI World. Its share peaked at 0.98% on Mar 31, 2020. The weight rises and falls with the stock's price performance relative to the other index members. It can also change when the index provider adjusts the index composition.
What's Inside Your ETF Portfolio and the ETF overlap check show how much Johnson & Johnson overlaps with the rest of a portfolio.
Which Tracked Investors Hold Johnson & Johnson?
Johnson & Johnson is not among the largest purchases in the quarter ending Jun 30, 2026. The list is led by GOOGL, DAL and NEBIUS GROUP N.V. Of the 2 tracked managers holding the stock, 2 cut.
| Investor | Shares | Value | Quarter |
|---|---|---|---|
| Bridgewater Associates | 669,135 | $170M | reduced by 27,749 |
| Soros Fund Management | 34,019 | $9M | reduced by 827 |
As of Jun 30, 2026. Based on quarterly filings with the US securities regulator, submitted up to 45 days after the reference date. The change counts shares, not price gains.
Stocks With ETF Exposure Similar to Johnson & Johnson
| Stock | Shared ETFs | r | 1 year | Annualized volatility | Net margin | Revenue growth |
|---|---|---|---|---|---|---|
| Johnson & Johnson | – | – | +44.5% | 19.6% | 28.5% | +6.0% |
 UnitedHealth Group Incorporated | 23 | – | +18.0% | 40.4% | 2.7% | +11.8% |
 AbbVie | 22 | +0.65 | +29.2% | 26.5% | 6.9% | +8.6% |
 Abbott Laboratories | 22 | – | -14.8% | 24.0% | 14.7% | +5.7% |
 Cardinal Health | 22 | – | +31.9% | 26.3% | 0.7% | +14.2% |
 Cencora | 22 | – | -3.0% | 26.1% | 0.5% | +9.3% |
 Eli Lilly and Company | 22 | +0.66 | +67.9% | 38.0% | 31.7% | +44.7% |
 West Pharmaceutical Services | 22 | – | +48.1% | 45.4% | 16.1% | +6.3% |
 Quest Diagnostics Incorporated | 22 | – | +43.3% | 22.9% | 9.0% | +11.8% |
These stocks reach a portfolio through largely the same funds as Johnson & Johnson. “Shared ETFs” counts the funds that hold both.
Return and volatility are calculated from our daily closing prices in US dollars. Margin and growth come from each company's latest SEC annual filing. Because fiscal years do not end on the same date for every company, the underlying periods are not fully identical.
Fundamental Analysis: Johnson & Johnson
Johnson & Johnson Key Financials
Figures come from the SEC annual filing for the latest reported fiscal year (period end Dec 28, 2025).
| Fiscal year | Revenue | Net income | Margin |
|---|---|---|---|
| FY ended Dec 2023 | 85.2 | 35.2 | 41.3% |
| FY ended Dec 2024 | 88.8 | 14.1 | 15.8% |
| FY ended Dec 2025 | 94.2 | 26.8 | 28.5% |
Latest Patents Granted to Johnson & Johnson
In the 52 weekly issues of the US patent office from Nov 4, 2025 to Oct 27, 2026, Johnson & Johnson received 64 utility patents and 1 design patents. That is 0.020% of all utility patents the US patent office granted in those weeks. The median time from filing to grant was 3.7 years.
| Granted | Patent | Title | Filed | Technology field |
|---|---|---|---|---|
| US 12775178 B2 | Fitting methods for astigmatic contact lens sets including apodized single vision lenses for lower cylinder error correction and toric lenses for higher cylinder error, and related astigmatic lens sets | G02C Physics | ||
| US 12773348 B2 | Intraocular pressure control system | A61F Human necessities | ||
| US 12773347 B2 | Apparatus, system, and method of gas infusion to allow for pressure control of irrigation in a surgical system | A61F Human necessities | ||
| US 12769150 B2 | Pupil dependent diffractive lens for near, intermediate, and far vision | G02C Physics | ||
| US 12766240 B2 | Anti-vacuum surge module with power and data transmission coils | A61M Human necessities |
These are grants, not applications. The office usually publishes an application 18 months after the priority date; the grant tends to come much later. Owners counted: Johnson & Johnson Surgical Vision, Inc. and Johnson & Johnson Vision Care, Inc. Titles as published by the office; median time based on 37 patents with a known filing date.
The patent screener lists more grants, filterable by company, type and technology field. The M&A and patents page compares companies.
Technical Analysis: Johnson & Johnson
Johnson & Johnson Risk Metrics
The close on Oct 30, 2026, was 1.9% below the highest close since Jul 11, 2024. That high was reached on Sep 3, 2026. When the S&P 500 rose or fell 1%, Johnson & Johnson moved 0.20% on average in the opposite direction (past 252 trading days). The correlation of -0.12, however, shows only a moderate link to the broad market. Accordingly, moves in the S&P 500 explain only a small part of the daily price moves of Johnson & Johnson.
What Johnson & Johnson Correlates With
| Instrument | r | −1 … +1 |
|---|---|---|
| Eli Lilly and Company | +0.66 | |
| AbbVie Inc. | +0.65 | |
| Royalty Pharma Plc Class A | +0.59 | |
| Vertex Pharmaceuticals Incorporated | +0.56 | |
| Gilead Sciences Inc. | +0.54 | |
| Amgen Inc. | +0.52 | |
| Texas Instruments Incorporated | -0.47 | |
| Monolithic Power Systems Inc. | -0.45 | |
| Teradyne Inc. | -0.44 |
The strongest co-movers are listed at the top, the strongest inverse movers at the bottom. Low or negative correlations can help spread risk more broadly across a portfolio.
